クリエートメディック(株)
株価チャート
2026/08/21 更新株価トレンド
2026/08/21 更新株価・取引詳細
2026/08/21 更新株価
取引
株主構成
2026/08/01 更新大株主
2026/08/01 更新| 機関名 | 保有比率 | 保有株数 | 変化 |
|---|---|---|---|
|
DFA Japanese Small Company Series
|
24.8K | -12.06% | |
|
SEI Institutional Managed Tr-Global Managed Volatility Fund
|
5.7K | 0.00% | |
|
SEI Institutional Investment Tr-Global Managed Volatility Fd
|
2.8K | 0.00% | |
|
DFA International Core Equity Portfolio
|
3.3K | 0.00% | |
|
Brighthouse Fds Tr II-BH/Dimensional International Small Co Port
|
1.8K | 0.00% | |
|
EQ Advisors Trust-EQ/International Value Managed Volatility Port
|
300 | 0.00% |
配当履歴
2026/08/23 更新| 年度 | 配当金 | 変化 |
|---|---|---|
| 2026 | ¥20 | -55.6% |
| 2025 | ¥45 | +15.4% |
| 2024 | ¥39 | +5.4% |
| 2023 | ¥37 | 0.0% |
| 2022 | ¥37 | - |
財務パフォーマンス
2026/08/23 更新売上・利益
利益率
キャッシュフロー
財務健全性
| 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|
| 損益計算書 | ||||
| 売上高 | ¥123億 | ¥126億 | ¥130億 | ¥136億 |
| 売上総利益 | ¥54億 | ¥55億 | ¥57億 | ¥60億 |
| 営業利益 | ¥7億 | ¥8億 | ¥7億 | ¥10億 |
| 経常利益 | ¥9億 | ¥9億 | ¥11億 | ¥11億 |
| 当期純利益 | ¥5億 | ¥2億 | ¥8億 | ¥7億 |
| EPS | ¥53.00 | ¥16.92 | - | ¥80.75 |
| 営業利益率 | 6.01% | 6.38% | 5.31% | 7.38% |
| 貸借対照表 | ||||
| 総資産 | ¥189億 | ¥193億 | ¥200億 | ¥201億 |
| 純資産 | ¥147億 | ¥149億 | ¥158億 | ¥163億 |
| 総負債 | ¥41億 | ¥43億 | ¥43億 | ¥38億 |
| 現金 | ¥43億 | ¥44億 | ¥63億 | ¥58億 |
| 有利子負債 | ¥8億 | ¥8億 | ¥8億 | ¥7億 |
| 自己資本比率 | 78.05% | 77.60% | 78.57% | 81.08% |
| D/Eレシオ | 0.05 | 0.05 | 0.05 | 0.05 |
| キャッシュフロー | ||||
| 営業CF | ¥5億 | ¥7億 | ¥22億 | ¥5億 |
| 投資CF | ¥0億 | -¥4億 | ¥3億 | -¥6億 |
| 財務CF | -¥4億 | -¥4億 | -¥9億 | -¥6億 |
| フリーCF | ¥1億 | ¥2億 | ¥18億 | ¥1億 |
| 効率性 | ||||
| ROE | 3.28% | 1.03% | 5.34% | 4.37% |
| ROA | 2.56% | 0.80% | 4.19% | 3.54% |
最新IR情報
-
2026年 第2四半期 連結決算報告
売上高は海外比率を拡大、国内市場の伸長と海外売上のバランスを示す。2026年2Q...
詳細を読む -
2026年12月期 第2四半期(中間期)決算短信〔日本基準〕(連結)
2026年12月期中間期の連結業績は売上高6,932百万円(前年同期比5.6%増...
詳細を読む -
第 2 四半期(中間期)業績予想と実績値との差異 および通期連結業績予想の修正に関するお知らせ
2026年中間期の実績と前回予想との差異を公表。売上高は実績が予想を上回るも、利...
詳細を読む -
自己株式の取得状況に関するお知らせ
2026/7/1〜2026/7/31にかけて普通株式35,300株を40,066...
詳細を読む -
自己株式の取得状況に関するお知らせ
詳細を読む
最新ニュース (5件)
企業情報
会社概要
Create Medic Co., Ltd. engages in the research, manufacturing, and sale of medical appliances in Japan, China, Vietnam, and internationally. The company offers urology products, including all silicone foley, antibacterial foley, hematuria, tieman, suprapubic, and nephrostomy balloon catheters, as well as self-catheterization set, all silicone self-catheter for replacement, pure-cath, nephrostomy kit, cystostomy set, and all silicone malecot catheter; and gastroenterology products, such as all silicone ileus, stomach, and sengstaken blakemore tubes, as well as transanal ileus decompression tube set. It also provides PEG products comprising PEG kit pull-method, with loop fixture, and bumper type, as well as CLINY introducer PEG kit, loop fixture II, all silicone gastrostomy balloon catheter for replacement, balloon button set, facil button for replacement, gastrostomy replacement catheter set, all silicone PEG J catheter, and transgastric jejunal balloon tube and guidewire set; surgery products, which include PTC drainage tube, PTCD kit, cholangio-entero tube, and internal external drainage catheter for PTCD; all silicone endotracheal and tracheostomy tubes and micro catheter; and OEM products. The company was formerly known as NASK Co., Ltd. and changed its name to Create Medic Co., Ltd. in July 1977. The company was incorporated in 1974 and is headquartered in Yokohama, Japan.